Post-marketing drug safety surveillance of enfortumab vedotin: an observational pharmacovigilance study based on a real-world database
The disproportionality analysis highlights that dermatologic toxicity and peripheral neuropathy were the major AEs induced by EV. The potential AEs not listed on the drug label were mainly related to gastrointestinal, hepatic, and pulmonary events. Further research is needed to confirm and explore the EV-related AEs in clinical practice.
Authors
- Mengda Cao (ORCID: https://orcid.org/0000-0002-7402-5046)
- Mingming Yu (ORCID: https://orcid.org/0000-0001-9957-6568)
- Chunmei Ji
- Li‐Jun Zhou
- Yuanyi Zheng
Institutions
- Shanghai Jiao Tong University (CN)
- Zhongda Hospital Southeast University (CN)
- Shanghai Sixth People's Hospital (CN)
- Jiangsu Province Hospital (CN)
- Shanghai Children's Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-08-20
- DOI
- https://doi.org/10.3389/fimmu.2024.1397692
- Citations
- 9
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 4.03
Funders
- National Natural Science Foundation of China